Cost pressure from Middle East disruptions
Packaging material costs are rising due to Middle East tensions, and CMO partners may pass on cost increases, though management expects limited profitability impact.
JAGSONPALPHARMACEUTICALS / Q4-FY26 / risks
Keep the risk register visible.
Jagsonpal Pharmaceuticals · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Execution risk in new product launches
Management acknowledged that new product establishment takes over a year for prescription pickup, and some products may not achieve expected market traction.
Concentration risk in top 10 brands
Top 10 brands constitute 58-60% of sales; any slowdown in these brands could materially impact overall growth, though management sees balanced portfolio.